Department of Anesthesiology, University Hospital Großhadern, Ludwig-Maximilians-University of Munich, 81366, Munich, Germany.
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3007-13. doi: 10.1007/s10096-012-1654-2. Epub 2012 Jul 11.
Approximately 50 % of all clinically proven infections in critically ill patients are caused by Gram-positive bacteria. The timely and appropriate treatment of these infections is vital in order to avoid negative outcomes. Hence, fast and reliable methods are needed for the early detection and identification of microorganisms. Recently, direct mass spectrometry-based analysis of volatile organic compounds emitted by microorganisms has been employed to study Gram-negative bacteria. Here, we report a feasibility study of ion molecule reaction mass spectrometry (IMR-MS) for in vitro growth detection and species differentiation of selected Gram-positive bacteria that are frequently isolated in blood culture samples, namely, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, and Staphylococcus epidermidis. Ion molecule reaction mass spectrometry was used to analyze the headspace above cultures containing Gram-positive bacteria incubated at 37 °C starting with 10(2) colony-forming units (CFU)/ml. Measurements to determine the presence of volatile organic compounds were performed 4, 8, and 24 h after incubation, respectively. The detection of microbial growth was accomplished already after 8 h in cultures containing E. faecalis. After 24 h of incubation, characteristic mass spectra were obtained for all species. Processing these mass spectra by hierarchic clustering and principal component analysis (PCA) enabled us to differentiate between bacterial species. IMR-MS in conjunction with a cumulative end-point model provides the means for rapid growth detection and differentiation of Gram-positive bacteria on the species level, typically within an analysis time of less than 3 min per sample.
大约 50%的所有在危重病患者中临床证实的感染是由革兰氏阳性菌引起的。及时和适当的治疗这些感染是至关重要的,以避免负面的结果。因此,需要快速和可靠的方法来早期检测和鉴定微生物。最近,基于直接质谱分析微生物释放的挥发性有机化合物已被用于研究革兰氏阴性细菌。在这里,我们报告了离子分子反应质谱(IMR-MS)用于体外生长检测和选择的革兰氏阳性菌的种间分化的可行性研究,这些细菌经常在血液培养样本中分离出来,即粪肠球菌、屎肠球菌、金黄色葡萄球菌和表皮葡萄球菌。离子分子反应质谱用于分析在 37°C 下孵育的含有革兰氏阳性菌的培养物的顶空,起始浓度为 10(2)个菌落形成单位(CFU)/ml。分别在孵育后 4、8 和 24 h 进行挥发性有机化合物存在的测量。在含有粪肠球菌的培养物中,在孵育 8 h 后即可检测到微生物的生长。孵育 24 h 后,获得了所有种的特征质谱。通过层次聚类和主成分分析(PCA)处理这些质谱,使我们能够区分细菌种。IMR-MS 与累积终点模型相结合,为革兰氏阳性菌的快速生长检测和种间分化提供了手段,通常每个样本的分析时间不到 3 分钟。